CRENESSITY
Live / Allowed — Notice of allowance issued (as of 27 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99025787
- Mark type
- Design + words
- Filed
- 31 Jan 2025
- Published for opposition
- 02 Dec 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of adrenal insufficiency; pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
- Class 042 — Scientific and technological services: Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on other endocrine diseases and disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results
- Class 044 — Medical, beauty and agricultural services: Providing medical information; providing medical information to patients, medical professionals in the field of other endocrine diseases and disorders; providing medical information to insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals in the field of other endocrine diseases and disorders; on-line information services, namely, providing medical information to insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 27 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2025 — PUBLISHED FOR OPPOSITION
- 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Oct 2025 — DIVISIONAL PROCESSING COMPLETE
- 18 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 28 Aug 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Aug 2025 — ASSIGNED TO LIE
- 18 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 18 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Jun 2025 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 09 Jun 2025 — PRIORITY ACTION E-MAILED